Injection Pen Market. The global injection pen market is on track for substantial growth, with a forecasted compound annual ...

Three-fourths of U.S. adults are now overweight or have obesity, with nearly 260 million predicted to have overweight or ...

"Since more than half of U.S. adults who have taken GLP-1 receptor agonists state the therapy was difficult to afford, ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

Doctors Without Borders and other organisations representing people with diabetes picketed outside the offices of insulin pen ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...